ZBIO – zenas biopharma, inc. (US:NASDAQ)

News

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
Zenas Bio: Recent IPO With Late-Stage Candidate [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com